Benihoud K, Yeh P, Perricaudet M
Laboratoire de Vectorologie et Transfert de Gènes UMR1582 CNRS/Rhône-Poulenc Gencell/IGR Institut Gustave Roussy 94805, Villejuif, France.
Curr Opin Biotechnol. 1999 Oct;10(5):440-7. doi: 10.1016/s0958-1669(99)00007-5.
Recent endeavors in the development of adenovirus as a gene vector have focused on the modification of virus tropism, the accommodation of larger genes, and the increase in stability and control of transgene expression. Whereas partial or total deletions of viral genes increase the cloning capacity and partly reduce the cellular immune response, control of the humoral response, which often precludes efficient readministration, remains a challenge.
近期腺病毒作为基因载体的研发工作主要集中在改变病毒嗜性、容纳更大的基因以及提高稳定性和控制转基因表达方面。虽然病毒基因的部分或全部缺失增加了克隆能力并部分降低了细胞免疫反应,但控制体液免疫反应(这常常阻碍有效再次给药)仍是一项挑战。